Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Randomized, Double-blind, Comparison of the Efficacy and Safety of Amisulpride Versus Low-dose Amisulpride Plus Low-dose Sulpiride in the Treatment of Schizophrenia

This study has been terminated.
Information provided by (Responsible Party):
Ching-Hua Lin, MD, PhD, Kaohsiung Kai-Suan Psychiatric Hospital Identifier:
First received: June 3, 2012
Last updated: February 27, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):